ChromaDex Corporation

(CDXC) Trade

By |

Profile

ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted to improving human immune function. The company produces dietary supplements, skincare, pharmaceutics, and animal health products. Its segments include Consumer products, Ingredients segment and Analytical reference standards and services segment.

Contact Information

Website: www.chromadex.com
Email: InvestorRelations@chromadex.com
Main Phone: +1 310 388-6706
Address: 10900 Wilshire Boulevard
Address 2: Suite 650
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90024

Issuer Information

Exchange: NSC
CEO: Robert N. Fried
Employees: 110
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

Profile

ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted to improving human immune function. The company produces dietary supplements, skincare, pharmaceutics, and animal health products. Its segments include Consumer products, Ingredients segment and Analytical reference standards and services segment.

Contact Information

Website: www.chromadex.com
Email: InvestorRelations@chromadex.com
Main Phone: +1 310 388-6706
Address: 10900 Wilshire Boulevard
Address 2: Suite 650
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90024

Issuer Information

Exchange: NSC
CEO: Robert N. Fried
Employees: 110
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

$ 5.00 $ 0.23 (4.82%)
Last Price 5.00 Change $ 0.23 Change % 4.82 Tick N/A
Bid 4.87 Bid Size 100.00 Ask 5.06 Ask Size 300.00
Open 4.90 High 5.20 Low 4.90 Prev Close 4.77
Last Trade Volume 1.1 mi 52 Wk Hi 5.81 52 Wk Low 2.50
Market Cap 307.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,477,895.00 EPS (TTM) -0.51 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 10 19
Number of Buys 8 14
Number of Sells 2 5
Net Activity 37800 383133
Last 10 Buys Shares
Kevin M. Farr 1,000
Mark J. Friedman 1,000
Frank L. Jaksch 1,000
Robert N. Fried 1,000
Frank L. Jaksch 1,000
Stephen Allen 1,000
Robert N. Fried 1,000
Stephen Allen 1,000
Stephen Allen 1,000
Frank L. Jaksch 1,000
Last 10 Sell Shares
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10.5 10.5 10.5 10.5
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 9.25 9.25 9.25 9.25
Standard Deviation 1.77 1.77 1.77 1.77
Date of Most Recent Estimate 05/24/18 05/24/18 03/11/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1